scientific and microscope

Our clinical studies

We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.

 

Clinical studies

This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.

 

Total studies

0

Current studies

0

Oncology

0

Dermatology

0

Rare diseases

0

Others

0
Show more filters
Title Therapeutic area Phase Status Start date (Planned) End date

Emollients in the management of atopic dermatitis in children: prevention of flares

Dermatology Phase III Completed 07 February 2013 12 February 2014

Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne

Dermatology Phase IV Completed February 2013 20 February 2014

Phase II trial of oral vinorelbine in Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) positive mutation after failure or resistance to treatment with Tyrosine Kinase Inhibitors (TKI) in first line

Oncology Phase II Completed 01 December 2012 17 April 2015

Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastatic Non-Small-Cell Lung Cancer patients with squamous histological type

Oncology Phase II Completed 01 December 2012 19 May 2017

Randomised phase II study evaluating, as first-line chemotherapy, weekly oral vinorelbine as a single-agent versus weekly paclitaxel as a single-agent in estrogen receptor positive, HER2 negative patients with advanced breast cancer

Oncology Phase II Completed 04 October 2012 05 September 2018

Exploratory study of L.S.E.S.r. (PERMIXON® 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH, A multinational, multicen...

Urology Phase IV Completed 27 June 2012 08 October 2013

Effect of 3-month treatment with F2695 (75mg OD) on improving functional recovery of patients with ischemic stroke. A multicenter, randomised, double-blind, parallel-group, placebo-controlled study

Cardiovascular Phase II Completed 18 June 2012 11 February 2015

Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study

Central Nervous System Phase II Completed 16 June 2012 15 April 2013

Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)

Oncology Phase III Completed 02 April 2012 23 November 2018

Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg,

Central Nervous System Phase II Completed 15 February 2012 02 November 2012

A randomised, double blind, controlled, multicentre study in infants with infantile hemangioma to compare propranolol gel to placebo

Dermatology Phase II Completed 10 February 2012 09 May 2013

Efficacy of the V0034CR01B emollient on xerosis in children with atopic dermatitis. Randomised, vehicle-controlled, parallel-groups, double-blind study with an open label extension

Dermatology Phase III Completed 30 November 2011 24 May 2012

Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder

Urology Phase II Completed 11 July 2011 13 October 2011

Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract

Oncology Phase II Completed 30 June 2011 14 February 2015

V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study

Central Nervous System Phase II Completed 17 May 2011 30 April 2012

Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing". A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial

Muskuloskeletal Phase IV Completed 17 April 2011 20 June 2012

Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium

Oncology Phase II Completed 05 October 2010 22 November 2010

A phase II multicentric study in adults with acute myelogenous leukaemia (AML) in first complete remission (CR1) using IV BuCy2 in a once daily Bu regimen targeting a narrow therapeutic window prior t...

Oncology Phase II Completed 17 May 2010 19 June 2014

Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor breast cancer with bone metastases previously treated by a hormone therapy

Oncology Phase II Completed 10 April 2010 17 June 2015

A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy

Dermatology Phase I Completed 26 March 2010 29 May 2012

Get access to Partner's pivotal studies supporting our authorized drugs in Europe

Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below:

 

Melanoma

SPONSOR: PFIZER

Breast cancer 

SPONSOR: PUMA BIOTECHNOLOGY

Colorectal cancer

SPONSOR: PFIZER

Post-transplantation lymphoproliferative disease EBV+

SPONSOR: ATARA